News Stories
A Better Life for Bubbles
With a charming personality, Bubbles—a 3-month-old black, brown, and white Shih Tzu—lives up to her name. But it wasn’t her sparkling disposition that led to the moniker; Bubbles received her name because she was born with meningoencephalocele—a rare, abnormal sac of fluid, brain tissue, and meninges (the membranes that cover the brain and spinal […]
Healing Kash
The unprecedented devastation caused by Hurricane Harvey displaced countless people. Many were forced out of their homes to find shelter because of the extensive flooding, the damage from which claimed almost everything they owned. Port Arthur resident Charles Moss lost his home and many of his belongings in the storm, and, for a night, […]
Texas A&M, Cornell Collaborate to Advance Education Research, Expand Pipeline for Underrepresented Students
Texas A&M and Cornell universities have joined forces to advance research on antimicrobial resistance (AMR) in veterinary medical education and to expand the pipeline for underrepresented students in the field. Funded by a $300,000 federal grant from the United States Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA), researchers from both universities […]
Texas A&M Study Links Breast Cancer, Body’s Internal Clock
For years, doctors have associated the BRCA1 and BRCA2 gene mutations with an increased risk of breast cancer. But researchers at Texas A&M University have now identified another gene that may have an impact on breast cancer—associated with the body’s circadian rhythm. Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM) professor Weston Porter […]
Three CVM Profs Awarded for University-Level Distinguished Achievement
Three faculty members at the Texas A&M College of Veterinary Medicine & Biomedical Sciences are among the 24 university faculty and staff to be recognized with a 2018 Distinguished Achievement Award by Texas A&M University and The Association of Former Students (AFS). University-level Distinguished Achievement Awards were presented to Joanne Hardy and Michelle Pine for […]
CVM Alumni Recognized for Contributions to Fields, Communities
The Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM) recognized five alumni for their commitment, service, and leadership in the veterinary and biomedical sciences fields, as well as to their communities. The annual Outstanding Alumni reception and dinner, held on April 27 at Bryan’s Miramont Country Club, honored 2018 Outstanding Alumni Award winners […]
Texas A&M Study Offers New Virus-Host Protein Insight, New Possibilities for Antiviral Development
Viruses have a very limited set of genes and, therefore, must use the cellular machineries of their hosts for most parts of their growth. In a new study, scientists at Texas A&M and Uppsala universities have discovered a specific host protein that many viruses use for their transport within the cell. The human gene, ZC3H11A, […]
A&M Research Receives FDA Orphan-Drug Designation for Angelman Syndrome Treatment
College Station, Texas — The U.S. Food and Drug Administration has granted orphan-drug designation to GTX-101 for the treatment of Angelman syndrome, a rare neurogenetic disorder that affects approximately 1 in 15,000 people. GTX-101 is the first drug candidate for startup GeneTx Biotherapeutics, LLC (GeneTx). “No approved treatments for Angelman syndrome exist today,” said Allyson […]
Leading the Flock
As the new director of Texas A&M’s Schubot Exotic Bird Health Center, Dr. Sarah Hamer brings an array of professional experience and, most importantly, a passion for studying and preserving native and exotic bird species. As a graduate student at the University of Illinois, Dr. Sarah Hamer spent countless hours inspecting trees and bushes and […]
Angelman Syndrome Treatment Being Investigated
Research from the laboratory of Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM) associate professor Scott Dindot has become the basis for an investigational antisense drug that researchers hope will lead to the treatment of Angelman syndrome (AS). Investigational-new-drug-enabling studies on the potential therapeutic are currently underway with GeneTx Biotherapeutics LLC (GeneTx), a […]
